Medication Guide App

MYLAN 2045 MYLAN 2045 (Tacrolimus 0.5 mg)

Pill imprint MYLAN 2045 MYLAN 2045 has been identified as Tacrolimus 0.5 mg.

Tacrolimus is used in the treatment of organ transplant, rejection prophylaxis; organ transplant, rejection reversal; graft-versus-host disease; crohn's disease and belongs to the drug class calcineurin inhibitors. Risk cannot be ruled out during pregnancy. Tacrolimus 0.5 mg is not subject to the Controlled Substances Act.

See also related documents.

Images for MYLAN 2045 MYLAN 2045 (Tacrolimus 0.5 mg)

Pill Identifier

Search by Imprint, Shape or Color

Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...

Search by Drug Name

Search by National Drug Codes (NDC)

Hide
(web1)